Dr. Leigh Ann Burns Naas Gilead Sciences, Inc., USA

Dr. Burns Naas PhD, DABT, ATS, ERT is Vice President of Drug Safety Evaluation at Gilead Sciences, Inc. Prior to this, she worked for 10 years in Drug Safety R&D at Pfizer as a Therapeutic Area Leader in multiple areas including anti-infectives, oncology, and vaccines. Her work has focused on... read morestrategic aspects and the design of safety programs to support chemical product development and registration, and to support the clinical development and licensure for small molecules and biotherapeutics, including vaccines. Leigh Ann completed her graduate training in pharmacology and toxicology (immunotoxicology) at the Medical College of Virginia/VCU and postgraduate training in biochemical and molecular immunology at the Mayo Clinic. Her recent immunologic research interest has been in the area of developmental immunotoxicology. Leigh Ann is a Past-President of the Immunotoxicology Specialty Section of the Society of Toxicology, a Past-President of the American College of Toxicology and a member of the Editorial Board for the International Journal of Toxicology.